Cormorant Asset Management »

Bridgebio Pharma shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $135M 3.3M 40.37
2023-09-30 $123M 4.7M 26.37
2023-06-30 $86M 5.0M 17.20
2023-03-31 $76M 4.6M 16.58
2022-12-31 $10M 1.4M 7.62
2022-09-30 $15M 1.5M 9.94
2022-06-30 $13M 1.5M 9.08
2022-03-31 $16M 1.6M 10.15
2021-12-31 $28M 1.7M 16.68
2021-09-30 $83M 1.8M 46.87
2021-06-30 $115M 1.9M 60.96
2021-03-31 $134M 2.2M 61.60
2020-12-31 $161M 2.3M 71.11
2020-09-30 $85M 2.3M 37.52
2020-06-30 $85M 2.6M 32.61
2020-03-31 $86M 3.0M 29.00
2019-12-31 $88M 2.5M 35.05
2019-09-30 $56M 2.6M 21.47
2019-06-30 $75M 2.8M 26.97